Results
|
|
58321.
|
|
|
|
58322.
|
|
|
|
58323.
|
|
|
|
58324.
|
The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors. [electronic resource] by
- Yamamoto, N
- Murakami, H
- Nishina, T
- Hirashima, T
- Sugio, K
- Muro, K
- Takahashi, T
- Naito, T
- Yasui, H
- Akinaga, S
- Koh, Y
- Boku, N
Producer: 20131118
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
|
58325.
|
|
|
|
58326.
|
|
|
|
58327.
|
|
|
|
58328.
|
|
|
|
58329.
|
|
|
|
58330.
|
|
|
|
58331.
|
|
|
|
58332.
|
|
|
|
58333.
|
|
|
|
58334.
|
|
|
|
58335.
|
|
|
|
58336.
|
|
|
|
58337.
|
|
|
|
58338.
|
|
|
|
58339.
|
|
|
|
58340.
|
|